Methods & Compositions for the Activation of Gamma-delta T-cells JP


Docket No:

Publication Number:
2019-501661 7260898

Patent Expiry:

Claims Scope:

Patent issued April 11, 2023. 


90% Sequence Identity – Compositions & Method-like claims 


Systems and “compositions for use in treating cancer” comprising helper and envelope plasmids, and a therapeutic plasmid having either shRNA or microRNA directed against SEQ ID NO 59 (FDPS targets sequence #4), comprising shRNA SEQ 4, or microRNA SEQ 5-6. 


Includes combination claims with aminobisphosphonates 


Notably shRNA SEQ 1-3 not allowed, nor microRNA 7-10.